‹ TLX latest research

TLX (Telix Pharmaceuticals Limited): every AI call and what happened next

TradeFlare's AI research teams analysed TLX on 7 market nights between May 8, 2026 and September 25, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

7 calls 5 BUY · 2 HOLD · 0 SELL BUY calls up after 20 trading days: 2 of 5
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
September 25, 2026 HOLD $11.31 — / — -7.9% not yet
The current setup does not warrant a buy due to conflicting signals and risk factors.
September 18, 2026 HOLD $12.51 $14.39 / $10.63 -9.1% not yet
The PEAD signal suggests potential for short-term follow-through, but the high volatility and mixed technicals warrant a cautious approach.
September 10, 2026 BUY $12.34 $14.76 / $10.49 +5.1% -7.5%
The bullish fundamental and sentiment signals, combined with the 52-week breakout, suggest potential for sustained upward momentum over several weeks.
August 21, 2026 BUY $12.42 $14.90 / $10.56 -0.3% -0.2%
The stock is poised for a breakout above resistance, supported by strong fundamentals and sentiment, with a technical setup that suggests continuation.
July 21, 2026 BUY $10.51 $12.00 / $8.50 -6.7% +8.8%
The fundamental and sentiment teams are bullish, suggesting a longer-term recovery potential, while technicals offer a short-term bounce opportunity.
July 20, 2026 BUY $10.46 — / — -5.0% +11.6%
The stock is currently consolidating and requires a clearer directional signal before a trade can be initiated.
May 8, 2026 BUY $10.66 $13.80 / $9.06 -1.1% -13.7%
The insider buying provides a near-term catalyst, and the fundamental and sentiment data suggest a longer-term upward trend.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.